Pachymetry-guided keratoplasty useful for keratoconus

Article

Pachymetry-guided custom excimer laser–assisted lamellar keratoplasty is a useful surgical procedure for the treatment of moderate to advanced keratoconus.

Pachymetry-guided custom excimer laser–assisted lamellar keratoplasty is a useful surgical procedure for the treatment of moderate to advanced keratoconus.

The prospective noncomparative case series, led by Dr Leopoldo Spadea, Eye Clinic, University of L'Aquila, L'Aquila, Italy, examined 43 keratoconic eyes preoperatively and 3, 6, 12, and 24 months postoperatively. All patients underwent transepithelial excimer laser ablation.

The outcome measures were uncorrected (UDVA) and corrected (CDVA) distance visual acuities, manifest refraction, computerized videokeratography, pachymetry and endothelial specular microscopy.

Of the 43 eyes studied, 35 were included in the 24-month follow-up visit. UDVA was better than 20/60 in 16 patients and the CDVA was 20/40 or better in 31 patients. Mean refractive astigmatism was −2.11 D and mean spherical equivalent manifest refraction was -2.60 D.

The surgical procedure eradicates the need for an invasive procedure of penetrating keratoplasty.

The abstract can be found in the Journal of Cataract and Refractive Surgery.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.